Cardiovascular Week articles from October 2004

Cardiovascular Week archives from October 2004

Combination may provide a potential treatment of arterial thrombotic disorders.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cilostazol and dipyridamole synergistically inhibit human platelet aggregation Scientists in the United States report, "It has been previously shown that cilostazol (Pletal(R)), a drug for relief of...

Carbon monoxide may have two independent cardiotoxic effects.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Carbon monoxide may have two independent cardiotoxic effects. According to research from England, "Rat hearts were perfused for 30 minutes with buffer equilibrated with CO. Mean data for hearts...

Clinical benefit of statin-induced elevation of HDL-cholesterol is unclear.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report questions the clinical relevance of the effects of statins on HDL-cholesterol. Scientists in France report, "It has been established that the level of plasma high-density...

Perinatal factors could program an individual for risk of cardiovascular disease.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The role of the RAS in programming of adult hypertension was the focus of a recent report. Scientists in Denmark report, "The etiology of cardiovascular disease originally included two components: a...

Changes in rats correspond to changes relevant to CV diseases in humans.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The effects of psychological stress on autonomic control of heart in rats may prove useful in human study. According to a study from Japan, "The aim of this study was to examine the effects of...

Hazards of surgery and anesthesia for drug, alcohol abusers presented at meeting.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Substance abusers who think it's okay not to tell their oral and maxillofacial surgeon about their drug use are putting themselves at risk for surgical complications, even if they're having a procedure...

Patients with cardiac RyR defects had general anesthesia without complications.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes the use of volatile anesthetics and succinylcholine in patients with cardiac ryanodine receptor defects. According to the report from Finland, "Familial polymorphic...

Cellular mechanisms that control regulation of TASK-1 by PAF are examined.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Activation of protein kinase C epsilon inhibits the two-pore domain K[superscript]+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. "Activation of the...

Glycoproteins have a procoagulant role in collagen-dependent thrombus formation.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report described facilitating roles of murine platelet glycoprotein Ib and (alpha)IIb(beta)3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation. According to...

New treatments may soon include agents known as the metabolic modulators.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report discusses metabolic approaches to the management of ischemic heart disease. According to a published report from the United States, "The number of patients with coronary artery...

Responses to BK of peripheral arteries and coronary arteries correlated.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin was compared to those to acetylcholine. According to a study from Japan,...

Serial surveillance of patients is vital after arterial switch operation.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Risk factors for neo-aortic root enlargement and aortic regurgitation following arterial switch operation are described in a recent report. According to a study from the United States, "The...

Slowed VO[subscript]2 kinetics occur only with exercise of the affected limbs.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes pulmonary Vo[subscript]2 dynamics during treadmill and arm exercise in peripheral arterial disease. "Slowed pulmonary O[subscript]2 uptake (VO[subscript]2) kinetics in...

Vascular and valvular calcium levels linked.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A significant link between vascular and valvular calcium levels has been demonstrated. In a study conducted by cardiologists in the United States, the "epidemiology of and association between...

aPT IgG is a significant marker for deep vein thrombosis/pulmonary embolism.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A high prevalence of anti-prothrombin antibody has been reported in patients with deep vein thrombosis. According to published research from Japan, "...[Our] study was designed to determine the...

Gene-targeting experiments have elucidated AT[subscript]1 receptor functions.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes experiments with type I angiotensin (AT[subscript]1) receptor functions through gene targeting According to recent research published in the journal Acta Physiologica...

Chymase and carboxypeptidase A have key roles in generating and degrading Ang II.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Scientists have reported on the cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. "The octapeptide...

Conservative surgery suggested when isolated lesion causes aortic regurgitation.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Diagnosis, management, and treatment of traumatic aortic regurgitation were the focus of a recent report. "Traumatic aortic valve regurgitation is a rare complication of nonpenetrating thoracic...

Study addresses concern about association with ventricular tachyarrhythmias.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Ranolazine reduces the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. According to a study from the United States, "The new anti-anginal drug ranolazine causes a...

Smaller driver for artificial heart licensed by cardiac device company.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, has licensed a new smaller driver for its CardioWest Total Artificial...

Contributions of the A[subscript]3AR do not control vascular response to injury.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A[subscript]3 adenosine receptor deficiency does not influence atherogenesis. "Atherosclerosis is a multifactorial disease, the progression of which is modulated by several factors, including...

Improved understanding of atherogenesis has resulted in assessment techniques.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes novel diagnostic techniques for identifying patients at cardiovascular risk. Scientists in the United States report, "Techniques that enable the accurate and reproducible...

Paired iliac artery stent model helps determine drug-delivery device effect.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A paired iliac artery stent rabbit model allows researchers to determine the effect of a new drug-delivery device. According to a study from France, "Preventing coronary in-stent restenosis is a...

Vascular grafting is effective in revascularization.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Both native and synthetic vascular grafts can be used for revascularization procedures. "Performed since the 1950s, vascular grafting has opened modern era of vascular surgery," investigators in...

Inhibition of tissue factor can improve outcomes in atherothrombosis.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Atherothrombosis is a widespread disease with unpredictable and life-threatening consequences. According to a report from the United States, "Atherothrombosis, characterised by atherosclerotic...

Defibrillator manufacturer receives leadership award for product line.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Medtronic received a leadership award from Frost & Sullivan for its external defibrillator product line for demonstrating the most insight into customer needs and product demands. The award stems...

Researchers identify a cardiolipin-remodeling enzyme in the mouse.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- "ALCAT1 represents the first identified cardiolipin-remodeling enzyme from any living organism," researchers say. "Cardiolipin is a major membrane polyglycerophospholipid that is required for the...

ABP monitoring can ease obstacles of obtaining accurate BP in dialysis patients.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Abmulatory blood pressure monitoring can ease obstacles of obtaining accurate BP in dialysis patients. According to recent research published in the journal Seminars in Dialysis, "Ambulatory blood...

Medical technology company acquires assets of Coalescent Surgical.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (MDT) has acquired the assets of Coalescent Surgical, an innovative developer of proprietary technologies designed to connect vessels safely without sutures. Financial terms of the...

Company announces US$24.4 million in sterols sales agreement.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Forbes Medi-Tech, Inc., (FMTI) announced that it has secured a sterols sales agreement for US$24.4 million over a 3-year period beginning in January 2005. This new customer agreement is between...

Company focuses on regenerative medicine, sells blood conservation technology.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Gary Tureski, president and cofounder of Harvest Technologies Corp., discussed the recent sale of the assets of Harvest's blood conservation technologies to Haemonetics Corp., Braintree, Massachusetts....

Electrophysiology company enters relationship with Partners Equity Capital.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD), announced a strategic alliance with Partners Equity Capital Co. (PECC) to provide specialized financing programs to EP MedSystems' customers to facilitate the purchase of...

Medical-technology company establishes U.S. operations.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- CoreValve, SA, a privately held medical-technology company, announced that it has established U.S. operations in Irvine, California, and has hired a management and product-development team to...

NitroMed up; to present trial data at conference.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- NitroMed Inc.'s stock rose September 16, 2004, after the company confirmed that trial data on its heart drug, intended for black patients, will be presented at an industry conference. The shares...

Different calcium channel blockers exert different effects on MMP-2 expression.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts. According to a study from Japan, "The cardiac...

Supplemental carnitine and lipoic acid improve the glutathione redox system.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- [subscript]L-carnitine and [subscript]DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. According to a study from India,...

Cardiovascular drug cuts sudden cardiac death by 21%.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Ramipril, a high blood pressure and heart failure drug, can reduce the rate of sudden cardiac death and nonfatal cardiac arrest by 21% in people at high risk for heart attack or stroke, according to a...

Efficacy of biphasic defibrillators compared.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The efficacy of two biphasic external defibrillators have been compared. According to recent research from Ireland, "[l]imited data have been published on the use of external defibrillators that...

Training key to defibrillator success.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Because defibrillators are more affordable than ever, they are quickly becoming commonplace in schools, businesses and other public places such as airports. But ordinary people, even with training,...

Where are we going with community defibrillation?
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The estimated incidence of cardiac arrest is 1 per 1000 inhabitants per year. About 80% of these events happen at home. Although ventricular fibrillation (VF), the main cause of cardiac arrest, is...

NT-3 may be important for cardiac development.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Neurotrophin-3 and trkC are expressed in the outflow tract of the developing chicken heart. According to a report from the United States, "Transcripts encoding trkC and full-length (catalytic) trkC...

Maintaining baroreflex function during 6 months of CyA treatment may be pivotal.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Investigators recently examined six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts with a focus on serial baroreflex responses. According to a study from France,...

A3243G mtDNA mutation is linked to abnormal heart energetics and cardiomyopathy.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Study indicates that bioenergetics deficit is related to cardiac hypertrophy in patients with the A3243G mtDNA mutation. "Cardiomyopathy is a frequent cause of morbidity and mortality in patients...

Alemtuzumab may have a role in inducing important cardiac side effects.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sezary syndrome "Alemtuzumab is a monoclonal antibody to CD52 that has activity in T-cell leukemia and lymphoma. This study alms to...

Authors review cases of cardiothoracic surgery performed on Jehovah's Witnesses.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes surgical techniques and medical management of Jehovah's Witnesses requiring complex urgent cardiothoracic surgery. According to a report from the United States,...

Midazolam was a more effective antiemetic than ondansetron.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Midazolam was an effective antiemetic after cardiac surgery in a recently reported clinical trial. Investigators in India report, "Cardiac surgery has been associated with a significant incidence...

Angiogenesis fosters the formation of aortic valve stenosis.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Angiogenesis fosters the formation of aortic valve stenosis. "Here, we demonstrate the angiogenic response of valvular endothelial cells to aortic valve (AV) stenosis using a new ex vivo model of...

C-reactive protein raises heart disease risk by impairing angiogenic function.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- C-reactive protein raises heart disease risk by impairing angiogenic function. According to a study from South Korea, "C-reactive protein (CRP), a predictor of future cardiovascular diseases, has...

Cannabinoid depresses respiration and enhances sympathetic tone and vagal tone.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report described the central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. According to a study from Germany,...

Cx43 and Cx45 connexins form diverse channels.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cardiac connexins Cx43 and Cx45 form diverse gap junction channels with diverse electrical properties. Investigators in Switzerland report, "HeLa cells expressing rat connexin43 (Cx43) and/or mouse...

Echocardiography is key to discussing indications for and timing of surgery.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers in France report on the impact of echocardiography on indications for surgery in chronic mitral and aortic regurgitation. According to the report, "Echocardiography is the key...

Effects of chronic hypoxia are described.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers report on the performance of the chronically hypoxic young rabbit heart. According to a recent report from the United States, "Hearts isolated from 30 rabbits, raised from birth to ~5...

Lysophosphatidic acid stimulates the adventitia to produce adrenomedullin.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report described the effects of adrenomedullin on cell proliferation in rat adventitia induced by lysophosphatidic acid. "Lysophosphatidic acid (LPA) is a bioactive phospholipid having...

Mild exercise training does not increase MCT4; causes complex changes in MCT1.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report described the relationship between skeletal muscle MCT1 and accumulated exercise during voluntary wheel-running. Researchers in Japan reported, "We examined whether the quantity of...

No evidence reported for phospholipase D activation by GI or IPC.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- According to recent research, there is no evidence for a role of phospholipase D in the release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by...

Troponin sense and antisense interactions form the basis for a new hybrid RNA.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Troponin sense and antisense interactions form the basis for a new hybrid RNA. According to recent research from Germany, "conformational changes in the troponin/tropomyosin complex significantly...

Epo has untapped potential in cardiac treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report provides an update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learned from studies in neuroprotection. According to the report from...

Statins mobilize endothelial progenitor cells to improve cardiac function.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Statins mobilize endothelial progenitor cells to improve cardiac function. "Statins are potent drugs with a variety of cardiovascular protective effects which appear to occur independent of...

Calcium-free products bind phosphate without cardiovascular calcification.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A new report describes the challenges and trends in calcium and phosphorus management in chronic kidney disease. According to the report from the United States, "Common and serious comorbidities in...

Cardiac rehab keeps heart patients fit, healthy.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- David Targove never skips his regular workouts in the cardiopulmonary rehabilitation program at Boswell Memorial Hospital in Sun City, Arizona. The Sun City winter visitor had an aortic valve...

Endoglin plays a key role in cardiovascular development and vascular remodeling.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the LIM family of proteins. According to recent research published in the Journal of Biological Chemistry,...

Radiological peritoneovenous shunt insertion feasible for intractable ascites.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Radiological peritoneovenous shunt insertion is feasible for the treatment of intractable ascites. "Ascites often contributes to patient morbidity and discomfort," radiologists in England...

Animal health company launches trials on dogs with heart diseases.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- In October 2004 Orion Pharma Animal Health will launch extensive clinical field studies on dogs with heart diseases. The aim of the project is to develop treatment for dogs with heart problems. ...

Giant coronary artery aneurysm rupture due to Kawasaki disease reported.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A giant coronary artery aneurysm rupture caused by Kawasaki disease has been reported. "Coronary artery aneurysm requiring surgery is rare," thoracic surgeons in China noted. T.M.T. Hwong and...

Par Pharmaceutical enters marketing agreement to its nitroglycerin lingual spray.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- NovaDel Pharma Inc. (AMEX:NVD) announced that is has entered into a licensing agreement with Par Pharmaceutical (NYSE:PRX) to market its nitroglycerin lingual spray. In June, NovaDel filed a new...

Treatment of intrastent restenosis reviewed.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The surgical and pharmacological treatment options for patients with intrastent restenosis (ISR) have been reviewed. ISR "remains an important limitation after stent implantation occurring in...

CV capacity, quadriceps muscle strength play modest role in rapid walking.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent study examined associations between walking time, quadriceps muscle strength and cardiovascular capacity in patients with rheumatoid arthritis and ankylosing spondylitis. According to the...

Hemostatic factors did not correlate with functional TAFI levels in plasma.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report describes the association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors...

Older workers with high workload showed poorer physical capacity.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A 16-year follow-up study addressed physical capacity in relation to perceived workload among ageing employees. Scientists in Finland report, "The main purpose of this study was to ascertain...

Medial prefrontal cortex has excitatory action on the sympathetic nervous system.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Research ahs been published on the pressor effects of electrical stimulation of medial prefrontal cortex in unanesthetized rats. Scientists from Brazil report, "The medial prefrontal cortex (MPFC)...

ZNF394 may play an important role in cardiac development, function.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Inhibition of transcriptional activities of AP-1 and c-Jun by a new zinc finger-protein ZNF394 has recently been reported. "Zinc finger proteins play important roles in a variety of cellular...

Ligusticum chuanxiong and Angelica sinensis protect ECV304 cells.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers recently reported on the protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Scientists in the People's Republic of...

NPC1L1 may be useful for treating hypercholesterolemia and sitosterolemia.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis "Niemann-Pick C1 Like 1 (NPC1L1) is a protein...

COPD patients prefer Respimat Soft MistTM Inhaler.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Respimat Soft MistTM Inhaler (SMI) represents a major step forward in inhalation therapy, resulting in high patient preference and satisfaction over other devices. The results of the analysis were...

New research targets management of COPD.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- New research into the management of chronic obstructive pulmonary disease (COPD), a debilitating respiratory illness, shows that patients treated with the inhaled drug Spiriva (tiotropium) experience...

Oxygen supplementation seems to be a promising treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A recent report discusses new strategies to improve exercise tolerance in chronic obstructive pulmonary disease. "Breathlessness is the most common symptom limiting exercise in patients with...

Phase 2 protocals submitted to U.S. FDA for clinical trials of synthetic blood.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Synthetic Blood International, Inc. (SYBD), has submitted the first of a series of phase 2 clinical trial protocols for Oxycyte to the U.S. Food and Drug Administration (FDA). Oxycyte is the...

Diagnostics company enters broad diagnostic collaboration with Compugen.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Diagnostic Products Corp. (DP) and Compugen, Ltd., (CGEN) announced a broad collaboration for the development and commercialization of novel diagnostic products, with an anticipated focus in the cancer...

Kiwifruit and aspirin have similar effects for heart health, study shows.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- If you've been taking aspirin daily to improve heart health, you'll be interested to know about a much tastier way to get the same effects. Eat 2 to 3 kiwifruit a day. Recent research conducted by...

Patient education about kava use in the perioperative period is suggested.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Anesthetic considerations of the herbal, kava, were the subject of a recent report. According to the report from the United States, "The herbal remedy, kava, is reviewed, with special focus on the...

Hibiscus flowers may prevent heart attacks.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Hibiscus flower extract may have the same health benefits as red wine and tea, according to new research by scientists in Taiwan. Hibiscus contains antioxidants that help control cholesterol levels...

Autopsy slides may provide clues to pathogenicity of maternal autoantibodies.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block is the subject of a recent report. "The mechanism by which maternal anti-SSA/Ro-SSB/La antibodies initiate and...

BNP concentration may be a useful tool in managing congenital heart disease.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- B-type natriuretic peptide levels in congenital heart disease According to published research from the United States, "The objective of [our] study was to evaluate the potential role of B-type...

CD4+ and CD8+ are altered in dogs with congestive heart failure.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure According to a study from the United States, "Alterations in lymphocyte subpopulations and in other...